Works matching IS 00071188 AND DT 2013 AND VI 169 AND IP 3

Results: 31

Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 619, doi. 10.1111/bph.12163

By:

Si, Yan ‐ Fang;
Wang, Jun;
Guan, Juan;
Zhou, Li;
Sheng, Yu;
Zhao, Juan

Publication type:

Article

Arginase inhibition alleviates hypertension in the metabolic syndrome.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 693, doi. 10.1111/bph.12144

By:

El ‐ Bassossy, Hany M;
El ‐ Fawal, Rania;
Fahmy, Ahmed;
Watson, Malcolm L

Publication type:

Article

Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 685, doi. 10.1111/bph.12162

By:

Rock, EM;
Parker, LA

Publication type:

Article

Retraction. Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit.

Published in:: 2013
Publication type:: corrected article

VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Published in:

2013

By:

Waschek, Ja;
Waschek, J A

Publication type:

journal article

PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.

Published in:

2013

By:

Molenaar, Peter;
Christ, Torsten;
Hussain, Rizwan I;
Engel, Andreas;
Berk, Emanuel;
Gillette, Katherine T;
Chen, Lu;
Galindo-Tovar, Alejandro;
Krobert, Kurt A;
Ravens, Ursula;
Levy, Finn Olav;
Kaumann, Alberto J

Publication type:

journal article

Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.

Published in:

2013

By:

Ullmer, C;
Alvarez Sanchez, R;
Sprecher, U;
Raab, S;
Mattei, P;
Dehmlow, H;
Sewing, S;
Iglesias, A;
Beauchamp, J;
Conde-Knape, K

Publication type:

journal article

Effects of the antianginal drug, ranolazine, on the brain sodium channel Na(V)1.2 and its modulation by extracellular protons.

Published in:

2013

By:

Peters, Ch;
Sokolov, S;
Rajamani, S;
Ruben, Pc;
Peters, C H;
Ruben, P C

Publication type:

journal article

Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.

Published in:

2013

By:

Uguen, M;
Perrin, D;
Belliard, S;
Ligneau, X;
Beardsley, Pm;
Lecomte, Jm;
Schwartz, Jc;
Beardsley, P M;
Lecomte, J M;
Schwartz, J C

Publication type:

journal article

Prostaglandin E₂-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells.

Published in:

2013

By:

Park, Tae Yeop;
Baik, Eun Joo;
Lee, Soo Hwan

Publication type:

journal article

Glycogen synthase kinase-3 (GSK-3) regulates TGF-β₁-induced differentiation of pulmonary fibroblasts.

Published in:

2013

By:

Baarsma, Hoeke A;
Engelbertink, Lilian Hjm;
van Hees, Lonneke J;
Menzen, Mark H;
Meurs, Herman;
Timens, Wim;
Postma, Dirkje S;
Kerstjens, Huib Am;
Gosens, Reinoud;
Engelbertink, Lilian H J M;
Kerstjens, Huib A M

Publication type:

journal article

In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.

Published in:

2013

By:

Freitas, K;
Negus, Ss;
Carroll, Fi;
Damaj, Mi;
Negus, S S;
Carroll, F I;
Damaj, M I

Publication type:

journal article

Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.

Published in:

2013

By:

Colucci, Rocchina;
Fornai, Matteo;
Duranti, Emiliano;
Antonioli, Luca;
Rugani, Ilaria;
Aydinoglu, Fatma;
Ippolito, Chiara;
Segnani, Cristina;
Bernardini, Nunzia;
Taddei, Stefano;
Blandizzi, Corrado;
Virdis, Agostino

Publication type:

journal article

Prostaglandin E2-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 604, doi. 10.1111/bph.12103

By:

Park, Tae Yeop;
Baik, Eun Joo;
Lee, Soo Hwan

Publication type:

Article

Systemic bile acid sensing by G protein-coupled bile acid receptor 1 ( GPBAR1) promotes PYY and GLP-1 release.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 671, doi. 10.1111/bph.12158

By:

Ullmer, C;
Alvarez Sanchez, R;
Sprecher, U;
Raab, S;
Mattei, P;
Dehmlow, H;
Sewing, S;
Iglesias, A;
Beauchamp, J;
Conde ‐ Knape, K

Publication type:

Article

Retraction.

Published in:: British Journal of Pharmacology, 2013, v. 169, n. 3, p. 717, doi. 10.1111/bph.12241
Publication type:: Article

PDE4 in the human heart - major player or little helper?

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 524, doi. 10.1111/bph.12168

By:

Eschenhagen, Thomas

Publication type:

Article

Glycogen synthase kinase-3 ( GSK-3) regulates TGF-β1-induced differentiation of pulmonary fibroblasts.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 590, doi. 10.1111/bph.12098

By:

Baarsma, Hoeke A;
Engelbertink, Lilian HJM;
Hees, Lonneke J;
Menzen, Mark H;
Meurs, Herman;
Timens, Wim;
Postma, Dirkje S;
Kerstjens, Huib AM;
Gosens, Reinoud

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2013, v. 169, n. 3, p. i, doi. 10.1111/j.1476-5381.2012.02158.x
Publication type:: Article

VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 512, doi. 10.1111/bph.12181

By:

Waschek, JA

Publication type:

Article

Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 659, doi. 10.1111/bph.12152

By:

Maher, Abdul R;
Arif, Sayqa;
Madhani, Melanie;
Abozguia, Khalid;
Ahmed, Ibrar;
Fernandez, Bernadette O;
Feelisch, Martin;
O'Sullivan, AG;
Christopoulos, Arthur;
Sverdlov, Aaron L;
Ngo, Doan;
Dautov, Rustem;
James, Philip E;
Horowitz, John D;
Frenneaux, Michael P

Publication type:

Article

HDL and endothelial protection.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 493, doi. 10.1111/bph.12174

By:

Tran ‐ Dinh, A;
Diallo, D;
Delbosc, S;
Varela ‐ Perez, L Maria;
Dang, QB;
Lapergue, B;
Burillo, E;
Michel, JB;
Levoye, A;
Martin ‐ Ventura, JL;
Meilhac, O

Publication type:

Article

Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 580, doi. 10.1111/bph.12145

By:

Changani, Kumar;
Hotee, Sarah;
Campbell, Simon;
Pindoria, Kashmira;
Dinnewell, Laura;
Saklatvala, Paula;
Thompson, Sally ‐ Anne;
Coe, Diane;
Biggadike, Keith;
Vitulli, Giovanni;
Lines, Marion;
Busza, Albert;
Denyer, Jane

Publication type:

Article

Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 645, doi. 10.1111/bph.12156

By:

Azcárate, IG;
Marín ‐ García, P;
Camacho, N;
Pérez ‐ Benavente, S;
Puyet, A;
Diez, A;
Ribas de Pouplana, L;
Bautista, JM

Publication type:

Article

PDE3, but not PDE4, reduces β1- and β2-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 528, doi. 10.1111/bph.12167

By:

Molenaar, Peter;
Christ, Torsten;
Hussain, Rizwan I;
Engel, Andreas;
Berk, Emanuel;
Gillette, Katherine T;
Chen, Lu;
Galindo ‐ Tovar, Alejandro;
Krobert, Kurt A;
Ravens, Ursula;
Levy, Finn Olav;
Kaumann, Alberto J

Publication type:

Article

Preclinical evaluation of the abuse potential of Pitolisant, a histamine H3 receptor inverse agonist/antagonist compared with Modafinil.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 632, doi. 10.1111/bph.12149

By:

Uguen, M;
Perrin, D;
Belliard, S;
Ligneau, X;
Beardsley, PM;
Lecomte, JM;
Schwartz, JC

Publication type:

Article

Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD( P) H oxidase and COX-1.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 554, doi. 10.1111/j.1476-5381.2012.02106.x

By:

Colucci, Rocchina;
Fornai, Matteo;
Duranti, Emiliano;
Antonioli, Luca;
Rugani, Ilaria;
Aydinoglu, Fatma;
Ippolito, Chiara;
Segnani, Cristina;
Bernardini, Nunzia;
Taddei, Stefano;
Blandizzi, Corrado;
Virdis, Agostino

Publication type:

Article

Role and interactions of annexin A1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 539, doi. 10.1111/j.1476-5381.2012.02146.x

By:

Hughes, Ellen L;
Cover, Patricia O;
Buckingham, Julia C;
Gavins, Felicity NE

Publication type:

Article

In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 567, doi. 10.1111/j.1476-5381.2012.02226.x

By:

Freitas, K;
Negus, SS;
Carroll, FI;
Damaj, MI

Publication type:

Article

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 477, doi. 10.1111/bph.12159

By:

Simões e Silva, AC;
Silveira, KD;
Ferreira, AJ;
Teixeira, MM

Publication type:

Article

Effects of the antianginal drug, ranolazine, on the brain sodium channel NaV1.2 and its modulation by extracellular protons.

Published in:

British Journal of Pharmacology, 2013, v. 169, n. 3, p. 704, doi. 10.1111/bph.12150

By:

Peters, CH;
Sokolov, S;
Rajamani, S;
Ruben, PC

Publication type:

Article

Works matching IS 00071188 AND DT 2013 AND VI 169 AND IP 3

Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.

Arginase inhibition alleviates hypertension in the metabolic syndrome.

Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats.

Retraction. Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit.

VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

PDE3, but not PDE4, reduces β₁ - and β₂-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.

Systemic bile acid sensing by G protein-coupled bile acid receptor 1 (GPBAR1) promotes PYY and GLP-1 release.

Effects of the antianginal drug, ranolazine, on the brain sodium channel Na(V)1.2 and its modulation by extracellular protons.

Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.

Prostaglandin E₂-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells.

Glycogen synthase kinase-3 (GSK-3) regulates TGF-β₁-induced differentiation of pulmonary fibroblasts.

In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.

Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1.

Prostaglandin E<sub>2</sub>-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells.

Systemic bile acid sensing by G protein-coupled bile acid receptor 1 ( GPBAR1) promotes PYY and GLP-1 release.

Retraction.

PDE4 in the human heart - major player or little helper?

Glycogen synthase kinase-3 ( GSK-3) regulates TGF-β<sub>1</sub>-induced differentiation of pulmonary fibroblasts.

Issue Information.

VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair.

Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite.

HDL and endothelial protection.

Effect of the TRPV1 antagonist SB-705498 on the nasal parasympathetic reflex response in the ovalbumin sensitized guinea pig.

Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

PDE3, but not PDE4, reduces β<sub>1</sub>- and β<sub>2</sub>-adrenoceptor-mediated inotropic and lusitropic effects in failing ventricle from metoprolol-treated patients.

Preclinical evaluation of the abuse potential of Pitolisant, a histamine H<sub>3</sub> receptor inverse agonist/antagonist compared with Modafinil.

Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD( P) H oxidase and COX-1.

Role and interactions of annexin A1 and oestrogens in the manifestation of sexual dimorphisms in cerebral and systemic inflammation.

In vivo pharmacological interactions between a type II positive allosteric modulator of α7 nicotinic ACh receptors and nicotinic agonists in a murine tonic pain model.

ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis.

Effects of the antianginal drug, ranolazine, on the brain sodium channel Na<sub>V</sub>1.2 and its modulation by extracellular protons.